LOXAPAC 50 mg/2 ml, solution for injection in an ampoule (IM) 10 ampoules of 2 ml
Active ingredients: Loxapine
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injection10 ampoules of 2 mlintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LOXAPAC 50 mg/2 ml, solution injectable en ampoule (IM)
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire
- Presentation description
- 10 ampoule(s) de 2 ml
- Marketing authorisation holder
- CNX THERAPEUTICS FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 29 Jul 2002
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Emergency use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69485940CIP75633098CIP133400956330980Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LOXAPINE BASEsolution | 50 mg · une ampoule de 2 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.